Loading...
Loading...
India's dolutegravir imports from UNITED STATES total $970.9K across 65 shipments from 15 foreign suppliers. ESPEE BIOPHARMA & FINECHEM LLC leads with $259.0K in import value; the top 5 suppliers together control 62.1% of this origin. Leading Indian buyers include HETERO LABS LIMITED. This corridor reflects India's pharmaceutical import demand for dolutegravir — a diversified sourcing base with multiple active suppliers from UNITED STATES.

ESPEE BIOPHARMA & FINECHEM LLC is the leading Dolutegravir supplier from UNITED STATES to India, with import value of $259.0K across 16 shipments. The top 5 suppliers — ESPEE BIOPHARMA & FINECHEM LLC, SPRING BIO SOLUTION, ESPEE BIOPHARMA FINECHEM LLC,, AMSTERDAM PHARMA (APTEKA RX INC.), Espee Biopharma & Finechem LLC — collectively account for 62.1% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ESPEE BIOPHARMA & FINECHEM LLC | $259.0K | 16 | 26.7% |
| 2 | SPRING BIO SOLUTION | $142.5K | 4 | 14.7% |
| 3 | ESPEE BIOPHARMA FINECHEM LLC, | $70.2K | 2 | 7.2% |
| 4 | AMSTERDAM PHARMA (APTEKA RX INC.) | $66.1K | 5 | 6.8% |
| 5 | Espee Biopharma & Finechem LLC | $64.7K | 3 | 6.7% |
| 6 | NewLife Medicals (USA). Inc. | $53.5K | 2 | 5.5% |
| 7 | SUN PHARMACEUTICAL INDUSTRIES INC. | $47.8K | 3 | 4.9% |
| 8 | SAVI CLINICALS FZ LLC | $38.8K | 2 | 4.0% |
| 9 | AGRACE PHARMA | $36.3K | 3 | 3.7% |
| 10 | NEWLIFE MEDICALS (USA). INC. | $26.9K | 1 | 2.8% |
| 11 | PREMIUM HEALTH SERVICES,INC. | $23.0K | 1 | 2.4% |
| 12 | Pharmaceutical Buyers, Inc | $18.8K | 2 | 1.9% |
| 13 | Good Health Pharma Supplies SS Drugs Inc | $18.1K | 1 | 1.9% |
| 14 | PHARMACEUTICAL BUYERS,INC. | $18.1K | 2 | 1.9% |
| 15 | M/S. PHARMACEUTICAL BUYERS INC. | $16.4K | 1 | 1.7% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | HETERO LABS LIMITED | $172.7K | 11 | 17.8% |
| 2 | LAURUS LABS LIMITED | $171.9K | 7 | 17.7% |
| 3 | EMCURE PHARMACEUTICALS LIMITED | $152.1K | 7 | 15.7% |
| 4 | MACLEODS PHARMACEUTICALS LTD | $110.0K | 5 | 11.3% |
| 5 | MYLAN LABORATORIES LIMITED | $97.1K | 11 | 10.0% |
| 6 | AUROBINDO PHARMA LTD | $65.7K | 3 | 6.8% |
| 7 | LAURUS LABS PRIVATE LIMITED | $64.2K | 1 | 6.6% |
| 8 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $47.8K | 3 | 4.9% |
| 9 | MACLEODS PHARMACEUTICALS LIMITED | $27.1K | 1 | 2.8% |
| 10 | ECRON ACUNOVA LIMITED | $16.4K | 1 | 1.7% |
| 11 | MICRO LABS LIMITED | $16.2K | 4 | 1.7% |
| 12 | DR.REDDY'S LABORATORIES LIMITED | $8.9K | 1 | 0.9% |
| 13 | CIPLA LIMITED | $5.9K | 2 | 0.6% |
| 14 | AJANTA PHARMA LIMITED | $5.5K | 3 | 0.6% |
| 15 | STRIDES PHARMA SCIENCE LIMITED | $4.3K | 3 | 0.4% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Dolutegravir suppliers from UNITED STATES to India include ESPEE BIOPHARMA & FINECHEM LLC, SPRING BIO SOLUTION, ESPEE BIOPHARMA FINECHEM LLC,. The leading supplier is ESPEE BIOPHARMA & FINECHEM LLC with import value of $259.0K USD across 16 shipments. India imported Dolutegravir worth $970.9K USD from UNITED STATES in total across 65 shipments.
India imported Dolutegravir worth $970.9K USD from UNITED STATES across 65 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Dolutegravir sourced from UNITED STATES include HETERO LABS LIMITED, LAURUS LABS LIMITED, EMCURE PHARMACEUTICALS LIMITED. The largest buyer is HETERO LABS LIMITED with $172.7K in imports across 11 shipments.
The total value of Dolutegravir imports from UNITED STATES to India is $970.9K USD, across 65 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
65 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists